Collection-image

TOPICAL COLLECTIONS

Stem Cells and Cancer: From Developmental Plasticity to Malignant Transformation
Submit Abstract

Guest Editor

Sharif Moradi

Sharif Moradi

Royan Institute for Stem Cell Biology and Technology, Department of Stem Cells and Developmental Biology

Dr. Sharif Moradi received his B.Sc. in Plant Biology from Khwarizmi University of Tehran in 2008 and his M.Sc. in Cell and Molecular Biology from the University of Tehran in 2010. He earned his PhD in developmental biology from Royan Institute in 2017, where he studied microRNA regulation in embryonic (ES) and induced pluripotent stem (iPS) cells. He has been a member of the Royan Institute since 2010 and was appointed assistant professor in 2018, leading a research group focused on non-coding RNAs, including microRNAs and siRNAs, in pluripotent stem cells and cancer. His lab investigates the molecular mechanisms of stem cell immortality and tumorigenicity, with a focus on developing oligonucleotide-based therapeutics and biosensors for early cancer detection. He serves as an academic editor for PLOS ONE and an editorial board member for the World Journal of Stem Cells and has chaired several international conferences in stem cell biology and cancer research. He is also the founder and CEO of miRas Biotech, a company dedicated to oligonucleotide-based diagnostics and therapeutics.

Collection Overview

The intersection of stem cell biology and cancer research offers a unique window into how tumors arise, evolve, and resist treatment. Cancer stem cells (CSCs) are now recognized as major contributors to tumor heterogeneity, metastasis, and relapse following conventional therapies. At the same time, cellular reprogramming technologies have opened new avenues for modeling cancer initiation and testing therapeutic strategies. Yet, despite these conceptual advances, methods across the two fields remain fragmented, making it difficult to compare results and translate findings across laboratories.


This Topical Collection seeks to address this challenge by assembling a curated set of reproducible, video-format protocols spanning three interconnected areas:

  1. Stem cell biology: Methods covering the derivation, maintenance, and differentiation of pluripotent and adult stem cells.
  2. Cancer biology: Techniques for studying tumor progression, metastasis, and therapeutic response.
  3. The stem cell-cancer interface: Protocols for cancer stem cell (CSC) isolation, reprogramming-based cancer models, and therapeutic strategies targeting self-renewal pathways.


By bringing together validated protocols from these domains, this collection will serve as an invaluable resource for researchers at all career stages. It will promote methodological standardization, encourage cross-disciplinary collaboration, and ultimately accelerate the translation of stem cell insights into better cancer diagnostics, prognostics, and treatments. We welcome contributions ranging from well-established techniques to emerging approaches, with a strong emphasis on clarity, practicality, and reproducibility.